Head and neck cancer - A clinicopathological study in a tertiary care center

Journal of the National Medical Association

Volumn 100, Issue 6, 2008, Pages 690-697

  Adeyemi, Bukola F ^a   Adekunle, Lola V ^a   Kolude, Bamidele M ^a   Akang, Effiong E U ^a   Lawoyin, Jonathan O ^a  

^a UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

Cancer; Head; Neck; Nigeria; Pathology

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BURKITT LYMPHOMA; CANCER PATIENT; CHILD; CHILDHOOD CANCER; CONNECTIVE TISSUE TUMOR; FEMALE; HEAD AND NECK CANCER; HEALTH CENTER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; NIGERIA; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RHABDOMYOSARCOMA; SEX DIFFERENCE; SQUAMOUS CELL CARCINOMA; TERTIARY HEALTH CARE; UNIVERSITY HOSPITAL;

EID: 45749109730     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-9684(15)31343-2     Document Type: Article

References (48)

1. Barnes L, Eveson J, Reichart P, et al. World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of the Head and Neck. Lyon: IARC Press; 2005.
2. Onakoya PA, Nwaorgu OG, Adenipekun AO, et al. Quality of Life in Patients with Head and Neck Cancers. J Natl Med Assoc. 2006;98(5):765-770.
3. Goldenberg D, Lee J, Koch WM, et al. Habitual risk factors for head and neck cancer. Otolaryngol Head Neck Surg. 2004;131(6):986-993.
4. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer. 1993;54:594-606.
5. Fan CY. Epigenetic alterations in head and neck cancer: prevalence, clinical significance, and implications. Curr Oncol Rep. 2004;6:152-161.
6. Otoh EC, Johnson NW, Danfillo IS, et al. Primary head and neck cancer in North Eastern Nigeria. West Afr J Med. 2004;23:305-313.
7. Ringström E, Peters E, Hasegawa M, et al. Molecular Oncology, Markers, Clinical Correlates. Human Papillomavirus type 16 and Squamous Cell Carcinoma of the Head and Neck. Clin Cancer Res. 2002;8:3187-3192.
8. Janot F, Klijanienko J, Russo A. Prognostic value of clinicopathological parameters in head and neck squamous cell carcinoma: a prospective analysis. Br J Cancer. 1996;73:531-538.
9. Ho JH. An epidemiologic and clinical study of nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 1978;4:182-198.
10. Chien YC, Chen JY, Liu MY, et al. Serologic Markers of Epstein-Barr Virus Infection and Nasopharyngeal Carcinoma in Taiwanese Men. N Engl J Med. 2001; 345:1877-1882.
11. Decker J, Goldstein JC. Risk factors in head and neck cancer. N Engl J Med. 1982; 306:1151-1155.
12. Ologe FE, Adeniji KA, Segun-Busari S. Clinicopathological study of head and neck cancers in Ilorin, Nigeria. Trop Doct. 2005;35:2-4.
13. Dubey SP, Sengupta SK, Kaleh LK. Adult head and neck lymphomas in Papua New Guinea: A retrospective study of 70 cases. ANZ J Surg. 1999;69(11):778-781.
14. McMains KC, Gourin CG. Pathology: Sarcomas of the Head and Neck. Journal of emedicine
15. Sturgis EM, BO. Sarcomas of the head and neck region. Curr Opin Oncol. 2003;15(3):239-252.
16. Adeyemi, BF, Kolude BM, Akang EEU, et al. A study of the utility of silver nucleolar organizer regions in categorization and prognosis of salivary gland tumors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;102:513-520.
17. Soames JV, Southam JC. Oral Pathology, 4th ed. Oxford University Press; 2005:136-143.
18. de la Torre J, Joseph E, Baibak LM. Head and Neck Cancer: Squamous Cell Carcinoma. Journal of emedicine 〈plastic surgery〉. www.emedicine.com/plastic/topic376.htm. Accessed 10/26/07.
19. Mendes RL, Nutting CM, Harrington KJ. Residual or recurrent head and neck cancer presenting with nerve roof compression affecting the upper limbs. Br J Radiol. 2004;77:688-690.
20. Pivot X, Niyikiza C, Poissonnet G, et al. Clinical prognostic factors for patients with recurrent head and neck cancer: implications for randomized trials. Oncology. 2001;61:197-204.
21. Jereczek-Fossa BA, Krengli M, Orecchia R. Particle beam radiotherapy for head and neck tumors: radiobiological basis and clinical experience. Head Neck. 2006;28(8):750-760.
22. Rowley H, McRae RD, Cook JA, et al. Lymphoma presenting to a Head and Neck Clinic. Clin Otolaryngol. 1995;20(2):139-144.
23. Tobias JS. Education and debate Current Issues in Cancer: cancer of the head and neck. BMJ. 1994:308:961-966.
24. Otoh EC, Johnson NW, Mandong BM, et al. Primary head and neck cancer in Jos, Nigeria: a revisit. West Afr J Med. 2006;25:92-100.
25. Kramárová E, Stiller CA, Ferlay J, et al. International Classification of Childhood Cancer. IARC Technical Report No. 29, International Agency for Research of Cancer. Lyon: 1996.
26. Bhatia PL. Head and neck cancer in Plateau State of Nigeria. West Afr J Med. 1990; 9:304-310.
27. Amusa YB, Olabanji JK, Ogundipe OV, et al. Pattern of head and neck malignant tumors in a Nigerian teaching hospital - a ten-year review. West Afr J Med. 2004;23:280-285.
28. Population Reference Bureau. 2006 World Population Data Sheet. www.prb.org/pdf06/06WorldDataSheet.pdf. Accessed 06/10/07.
29. Amusa YB, Adediran IA, Akinpelu VO, et al. Burkitt's lymphoma of the head and neck region in a Nigerian tertiary hospital. West Afr J Med. 2005;24:139-142.
30. DePeña CA, Van Tassel P, Lee YY. Lymphoma of the head and neck. Radiol Clin North Am. 1990;28(4):723-743.
31. Wright D. Burkitt's lymphoma - a Pathologist's Perspective. The International Network for Cancer Treatment and Research 2007. website: www.inctr.org/publications/2001_v02_n01_s08.shtml. Accessed 06/10/07.
32. Gordon M, Rishpon S, Gorski M. Delayed diagnosis of carcinoma of the oral cavity. Harefuah. 2005;144:243-245.
33. Canto MT, Devesa SS. Oral cavity and pharynx cancer incidence rates in the United States, 1975-1998. Oral Oncol. 2002;38:610-617.
34. Tarvainen L, Suuronen R, Lindqvist C, et al. Is the incidence of oral and pharyngeal cancer increasing in Finland? An epidemiological study of 17,383 cases in 1953-1999. Oral Dis. 2004;10:167-172.
35. Gervasio OLAS, Dutra RA, Tartaglia SMA, et al. Oral squamous cell carcinoma: a retrospective study of 740 cases in a Brazilian population. Braz Dent J. 2001;12:57-61.
36. Panchal L, Vaideeswar P, Kathpal D, et al. Sino-nasal epithelial tumors: a pathological study of 69 cases. J Postgrad Med. 2005;51:30-34.
37. Onyango JF, Awange DO, Njiru A, et al. Pattern of occurrence of head and neck cancer presenting at Kenyatta National Hospital, Nairobi. East Afr Med J. 2006;83:288-291.
38. Maier H, Dietz A, Gewelke U, et al. Tobacco and alcohol and the risk of head and neck cancer. Clin Invest. 1992;70:320-327.
39. Nwawolo CC, Ajekigbe AT, Oyeneyin JO, et al. Pattern of head and neck cancers among Nigerians in Lagos. West Afr J Med. 2001;20:111-116.
40. Haque R, Contreras R, McNicoll MP, et al. Surgical margins and survival after head and neck cancer surgery. BMC Ear Nose Throat Disord. 2006;6:2.
41. Schoenmaker N, Hermanides J, Davey G. Prevalence and predictors of smoking in Butajira town, Ethiopia. Ethiop J Health Dev. 2005;19:182-187.
42. Speight PM, Barrett AW. Salivary gland tumors. Oral Dis. 2002;8:229-240.
43. Kolude B, Lawoyin JO, Akang EEU. Salivary gland neoplasms: a 21-year review. Afr J Med Med Sci. 2001;30:95-98.
44. Auclair PL, Ellis GL, Gnepp DR, et al. Salivary gland neoplasms: general considerations. In: Ellis GL, Auclair PL, Gnepp DR, Eds.: Surgical Pathology of the Salivary Glands. Philadelphia: Saunders; 1991:135-164.
45. Wahlberg P, Anderson H, Biörklund A. Carcinoma of the parotid and submandibular glands - a study of survival in 2465 patients. Oral Oncol. 2002;38:706-713.
46. Kollert M, Draf W, Minovi A, et al. Carcinoma of the external auditory canal and middle ear: therapeutic strategy and follow up. Laryngorhinootologie. 2004;83:818-823.
47. Davies L, Welch HG. Epidemiology of head and neck cancer in the United States. Otolaryngol Head Neck Surg. 2006;135:451-457.
48. Lawoyin JO, Aderinokun GA, Kolude B , et al. Oral cancer awareness and prevalence of risk behaviors among dental patients in south western Nigeria. Afr J Med Med Sci. 2003;32:203-207.